West Michigan Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,742
Closed -$613K 307
2026
Q1
$613K Buy
1,742
+188
+12% +$67K 0.13% 166
2025
Q4
$509K Buy
1,554
+32
+2% +$10.2K 0.12% 164
2025
Q3
$430K Buy
1,522
+111
+8% +$32.2K 0.1% 162
2025
Q2
$394K Sell
1,411
-76
-5% -$21.5K 0.11% 137
2025
Q1
$463K Sell
1,487
-112
-7% -$33.1K 0.15% 109
2024
Q4
$417K Sell
1,599
-39
-2% -$11.6K 0.13% 120
2024
Q3
$528K Buy
1,638
+119
+8% +$38.9K 0.16% 102
2024
Q2
$475K Buy
1,519
+254
+20% +$74.6K 0.15% 104
2024
Q1
$360K Sell
1,265
-992
-44% -$290K 0.12% 119
2023
Q4
$650K Buy
2,257
+211
+10% +$57.5K 0.25% 67
2023
Q3
$550K Buy
+2,046
New +$511K 0.29% 69
2023
Q1
Sell
-961
Closed -$252K 157
2022
Q4
$252K Buy
+961
New +$258K 0.18% 90
2022
Q3
Sell
-828
Closed -$201K 112
2022
Q2
$201K Sell
828
-34
-4% -$8.33K 0.17% 107
2022
Q1
$208K Sell
862
-133
-13% -$30.6K 0.14% 121
2021
Q4
$224K Buy
+995
New +$210K 0.17% 111

Other funds holding AMGN

West Michigan Advisors's AMGN Position: Q2 2026 in Review

West Michigan Advisors sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,742 shares — an estimated $613K sold.

West Michigan Advisors first reported a position in AMGN in Q4 2021 and held it in 15 quarters. The position peaked at $650K in Q4 2023. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • West Michigan Advisors reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • West Michigan Advisors sold 1,742 Amgen shares in Q2 2026, an estimated $613K.
  • West Michigan Advisors first reported a position in Amgen in Q4 2021 and held it in 15 quarters.
  • West Michigan Advisors's Amgen position peaked at $650K in Q4 2023.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.